[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
[ Tue, May 24th 2022 ]: WOPRAI
Salveen Richter Maintained (ADPT) at Hold with Decreased Target to $10 on, May 24th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Salveen Richter of Goldman Sachs, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $14 to $10 on, May 24th, 2022.
Salveen has made no other calls on ADPT in the last 4 months.
There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $18 on, Friday, May 6th, 2022
This is the rating of the analyst that currently disagrees with Salveen
- Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, February 16th, 2022